Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.

The anti-diabetic medication “Ozempic” (semaglutide) made by Danish pharmaceutical company Novo Nordisk. Joel Saget | AFP | Getty Images The U.S. Senate has launched an investigation into the high price of Novo Nordisk‘s popular weight loss and diabetes drugs Ozempic and Wegovy in the United States, versus other countries where the drugs are sold. The … Read more

Biogen (BIIB) earnings Q1 2024

A test tube is seen in front of displayed Biogen logo in this illustration taken on, December 1, 2021. Dado Ruvic | Reuters Biogen on Wednesday reported first-quarter profit that topped estimates as the company’s cost-cutting efforts took hold and sales of its closely watched Alzheimer’s drug, Leqembi, came in higher than expected. Biogen and … Read more

3.6 million Medicare patients could get heart health coverage

More than 3 million people with Medicare could be eligible for coverage of Wegovy now that the blockbuster weight loss drug is also approved in the U.S. for heart health, according to an analysis released Wednesday by health policy research organization KFF. But some eligible beneficiaries could still face out-of-pocket costs for the highly popular … Read more

Swiss pharma giant Roche’s first-quarter sales edge higher as its emerges from post-Covid-19 slump

A logo at the Roche Holding AG headquarters in Basel, Switzerland, on Thursday, Feb. 1, 2024. Bloomberg | Getty Images Swiss pharmaceutical company Roche on Wednesday reported a modest uptick in first-quarter sales, even as waning demand for its Covid-19 products continued to weigh on the company. Sales were up 2% at constant exchange rates, … Read more

Biotech IPOs heated up, but haven’t fully recovered

Angelp | Istock | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! After a two-year dry spell, initial public offerings by biotech companies showed signs of life during the first three months of 2024.  But it’s too early to say that … Read more

Weight loss drug patients spend less on restaurants, takeout: survey

A food delivery messenger carries a take out bag outside aSweetgreen in Manhattan on September 14, 2023. Jeenah Moon | The Washington Post | Getty Images A highly popular group of weight loss and diabetes drugs is decreasing some consumers’ appetites — and also how much they spend on food. Most people taking those medications, … Read more

U.S. drug shortages reach record high, hitting Wegovy

Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024.  Hollie Adams | Reuters Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! Drug shortages in the U.S. are at a record high, leaving countless patients … Read more

Eli Lilly’s Zepbound, Mounjaro in short supply through June, FDA says 

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023.  Brendan McDermid | Reuters Most doses of Eli Lilly‘s highly popular weight loss drug Zepbound and diabetes counterpart Mounjaro will be in short supply through the second quarter of this year as demand jumps, according … Read more

Eli Lilly weight loss drug Zepbound effective in sleep apnea trials

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023.  Brendan McDermid | Reuters Eli Lilly on Wednesday said its highly popular weight loss drug Zepbound showed the potential to treat patients with the most common sleep-related breathing disorder in two late-stage clinical trials. The … Read more

Johnson & Johnson (JNJ) earnings Q1 2024

An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. Mark Ralston | AFP | Getty Images Johnson & Johnson on Tuesday reported first-quarter adjusted earnings that topped Wall Street’s expectations as sales in its medical devices business surged. Meanwhile, the company’s total revenue for the … Read more